News & Updates

Show Multimedia Only

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

10 Dec 2024

The post-pandemic burden of COVID-19 remains significant in adults. Four studies from IDWeek 2024 highlight the benefits of nirmatrelvir-ritonavir (NMV/r) for high-risk adults with SARS-CoV-2 immunity and link chronic conditions to COVID-19 hospitalization. Identifying high-risk patients and using NMV/r in outpatient settings can reduce severe outcomes.

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

10 Dec 2024

Cardiometabolic risk factors mediate link between body composition, bone mineral content

08 Dec 2024

The number of cardiometabolic risk (CMR) factors plays an important role in mediating the association between fat percentage and bone mineral content (BMC) percentage in children, suggests a study.

Cardiometabolic risk factors mediate link between body composition, bone mineral content

08 Dec 2024

Clinical considerations for patients at high risk for progression to severe COVID-19

07 Dec 2024

COVID-19 has not gone away. New contagious variants continue to be a leading cause of death, with underlying conditions still influencing the risk of COVID-19 hospitalizations, said Dr Ali Hassoun, Clinical Professor of Medicine and infectious disease specialist at Crestwood Medical Center, Huntsville, Alabama, US, who spoke at a Pfizer-sponsored session during IDWeek 2024.

Clinical considerations for patients at high risk for progression to severe COVID-19

07 Dec 2024

Age at T2DM diagnosis a major factor for subsequent adverse outcomes

05 Dec 2024 by

For individuals with type 2 diabetes mellitus (T2DM), the earlier the age at diagnosis, the higher the likelihood of subsequent coronary heart disease (CHD), stroke, cancer, and all-cause death, as shown in a study.

Age at T2DM diagnosis a major factor for subsequent adverse outcomes

05 Dec 2024

TRT shows promise as adjunct treatment in rehabilitating ICU patients

05 Dec 2024 by

Testosterone replacement therapy (TRT) has the potential to be an effective adjunct treatment in the rehabilitation of critically ill patients with intensive care unit (ICU)-associated weakness (AW) and hospital-associated deconditioning (HAD), according to a Singapore study.

TRT shows promise as adjunct treatment in rehabilitating ICU patients

05 Dec 2024

What drives the beneficial effects of tirzepatide on glycaemic control?

05 Dec 2024

Use of tirzepatide results in better glycaemic control when compared with semaglutide, as shown by improved fasting glucose and glucose excursion control brought about by improvements in insulin secretion rate (ISR), insulin sensitivity, and glucagon suppression, according to a study.

What drives the beneficial effects of tirzepatide on glycaemic control?

05 Dec 2024

Fezolinetant eases symptoms in menopausal women unfit for hormone therapy

04 Dec 2024 by

Use of fezolinetant demonstrates efficacy and good tolerability in the treatment of moderate-to-severe vasomotor symptoms associated with menopause in women who are deemed unsuitable for hormone therapy, reports a study.

Fezolinetant eases symptoms in menopausal women unfit for hormone therapy

04 Dec 2024

Food processing has no association with glycaemic index, load

02 Dec 2024

A recent study has found no difference in glycaemic index (GI) and glycaemic load (GL) between processing levels according to NOVA classification. However, GL is lower in ultraprocessed grains and vegetables than minimally processed foods (MPFs).

Food processing has no association with glycaemic index, load

02 Dec 2024

ADA 2022 guidelines improve prescribing rates of SGLT2 inhibitors in T2D patients

02 Dec 2024

The overall utilization rates of SGLT2 inhibitors have increased among patients with type 2 diabetes (T2D) following the release of the 2022 American Diabetes Association (ADA) guidelines.

ADA 2022 guidelines improve prescribing rates of SGLT2 inhibitors in T2D patients

02 Dec 2024

Good glycaemic control helps slow brain ageing

29 Nov 2024 by

Improved glycaemic control is a big contributor to the neuroprotective effects of Mediterranean (MED) and green-MED diets on brain age, a study has shown. In addition, polyphenols-rich diet components such as Mankai and green tea help prevent brain ageing.

Good glycaemic control helps slow brain ageing

29 Nov 2024

News & Updates

Showing Endocrinology articles

Showing

Specialty:

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

Cardiometabolic risk factors mediate link between body composition, bone mineral content

Cardiometabolic risk factors mediate link between body composition, bone mineral content

Clinical considerations for patients at high risk for progression to severe COVID-19

Clinical considerations for patients at high risk for progression to severe COVID-19

Age at T2DM diagnosis a major factor for subsequent adverse outcomes

Age at T2DM diagnosis a major factor for subsequent adverse outcomes

TRT shows promise as adjunct treatment in rehabilitating ICU patients

TRT shows promise as adjunct treatment in rehabilitating ICU patients

What drives the beneficial effects of tirzepatide on glycaemic control?

What drives the beneficial effects of tirzepatide on glycaemic control?

Fezolinetant eases symptoms in menopausal women unfit for hormone therapy

Fezolinetant eases symptoms in menopausal women unfit for hormone therapy

Food processing has no association with glycaemic index, load

Food processing has no association with glycaemic index, load

ADA 2022 guidelines improve prescribing rates of SGLT2 inhibitors in T2D patients

ADA 2022 guidelines improve prescribing rates of SGLT2 inhibitors in T2D patients

Good glycaemic control helps slow brain ageing

Good glycaemic control helps slow brain ageing